射频超声多光谱技术(REMS)用于系统性红斑狼疮(SLE)患者骨骼健康评估
本研究在106例SLE患者(44例接受糖皮质激素治疗)中比较REMS与DXA在腰椎、股骨颈和全髋的骨密度及骨质疏松诊断一致性。REMS在各部位测得的骨密度均显著低于DXA(p<0.001),骨质疏松分类一致性为轻度至中度(κ 0.229–0.549),诊断骨质疏松敏感度45%、特异度88.4%,两者对椎体骨折的判别能力相似。
要点
- REMS在腰椎、股骨颈和全髋测得的骨密度均显著低于DXA(p<0.001)。
- 骨质疏松分类一致性为轻度至中度,κ从腰椎0.229到GC治疗者股骨颈0.549。
- REMS诊断骨质疏松敏感度45%、特异度88.4%,与DXA对骨折风险判别能力相似。
核心结论
- REMS与DXA在SLE患者骨质疏松诊断和骨折判别中显示尚可至中度的一致性。
- REMS在此背景下似乎是一种支持性工具,尤其在GC治疗个体中,但需进一步纵向研究验证其预测价值和临床效用。
研究设计与样本
- 研究纳入106例SLE患者,其中44例接受糖皮质激素治疗,均接受DXA和REMS骨密度评估。
- 评估部位为腰椎、股骨颈和全髋,比较两种方法的骨密度和T值。
- 采用线性回归、Cohen kappa和Bland-Altman分析诊断一致性,用ROC曲线评估骨折判别能力。
主要发现
- REMS在所有骨骼部位的骨密度测量值均显著低于DXA(p<0.001)。
- 骨质疏松分类一致性为轻度至中度,κ从全部患者腰椎的0.229到GC治疗患者股骨颈的0.549。
- REMS诊断骨质疏松的敏感度为45%、特异度为88.4%。
- REMS与DXA在有和无椎体骨折患者间均识别出显著骨密度差异,ROC分析显示两者对骨折风险的判别能力相似。
- REMS骨密度值与年龄、性别和体重指数的关联更强。
关键数值与推荐
- REMS与DXA骨质疏松分类一致性κ范围:全部患者腰椎0.229至GC治疗患者股骨颈0.549。
- REMS诊断骨质疏松敏感度45%、特异度88.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需进一步纵向研究验证REMS的预测价值和临床效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The aim of this study was to evaluate the agreement between DXA and REMS in a cohort of SLE patients. REMS and DXA showed a fair to moderate agreement on osteoporosis diagnosis, with a similar ability to identify fracture risk. REMS tended to show lower bone mineral density and was more influenced by patients' demographics. BACKGROUND: The aim of this study was to assess the diagnostic agreement between Radiofrequency Echographic Multi Spectrometry (REMS) and dual-energy X-ray absorptiometry (DXA) for bone mineral density (BMD) in patients with systemic lupus erythematosus (SLE), particularly those receiving glucocorticoids (GCs). METHODS: One hundred-six SLE patients (44 GC-treated) underwent BMD assessment at the lumbar spine (LS), femoral neck (FN), and total hip (TH) using both DXA and REMS. We compared BMD and T-scores between methods and analyzed diagnostic agreement using linear regression, Cohen's kappa and Bland-Altman analysis. Receiver operator characteristic (ROC) curves evaluated the ability of REMS and DXA to discriminate fracture status. RESULTS: BMD measurements at all sites were significantly lower with REMS when compared with DXA across all skeletal sites (p < 0.001). Agreement in osteoporosis classification was slight to moderate (κ ranging from 0.229 at LS in all patients to 0.549 at FN in GC-treated patients). REMS showed moderate correlation with DXA and demonstrated 45% sensitivity and 88.4% specificity for diagnosing osteoporosis. Both REMS and DXA identified significant BMD differences between patients with and without vertebral fractures across all sites. ROC analysis revealed similar discriminative ability for fracture risk between REMS and DXA. REMS BMD values were more strongly associated with age, sex, and body mass index. CONCLUSION: REMS and DXA showed a fair to moderate agreement in osteoporosis diagnosis and in fracture discrimination in SLE patients. While REMS appears a supportive tool in this setting, particularly in GC-treated individuals, further longitudinal studies are warranted to validate its predictive value and clinical utility.
引用
- Lopes MD, Orsolini G, Galvagni I, et al. Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE). Osteoporos Int. 2025. PMID: 41444447. doi:10.1007/s00198-025-07824-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。